Koyfin Home > Directory > Health Care > Antares Pharma > Net Debt / EBITDA

Antares Pharma Net Debt / EBITDA Chart (ATRS)

Antares Pharma annual/quarterly Net Debt / EBITDA from 2019 to 2019. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
Other Ratios Metrics:
  • Antares Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $39m a -19.64% decrease of -8m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
  • Antares Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $64m a -36.97% decrease of -24m year over year
View Chart On Koyfin